Ajanta Pharma P/E Ratio
Ajanta Pharma (AJANTPHARM) P/E ratio is 40.43 (High), EPS (TTM) ₹84.53, current price ₹3369.50 on NSE vs historical average P/E of 21.47 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Ajanta Pharma share price chart.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AJANTPHARM P/E Ratio — Valuation Signal & Historical Context
Ajanta Pharma P/E 40.43 vs historical average 21.47, range 9.1–36.89 — signal: Overvalued. See AJANTPHARM P/B ratio history to compare market price against book value per share.
- Stock appears overvalued with PE of 40.43, suggesting caution for new investments
- Current PE is 88.3% above historical average
- Trading at discount to sector average PE of 55.72
Ajanta Pharma P/E Ratio Historical Trend
AJANTPHARM annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 40.43 vs historical average 21.47. Read AJANTPHARM dividend growth for the complete payout history and dividend yield track record.
AJANTPHARM Historical P/E Ratio — EPS, Year-End Price & Valuation
Ajanta Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 36.89 | 81.18 | ₹2994.35 | NSE | High |
| 2024 | 30.2 | 71.51 | ₹2159.65 | NSE | High |
| 2023 | 20.73 | 58.26 | ₹1207.75 | NSE | Moderate |
| 2022 | 27.31 | 54.05 | ₹1476.15 | NSE | High |
| 2021 | 14.53 | 75.74 | ₹1100.70 | NSE | Low |
| 2020 | 9.1 | 71.65 | ₹652.30 | NSE | Low |
| 2019 | 16.11 | 48.91 | ₹787.80 | NSE | Moderate |
| 2018 | 22.32 | 44.61 | ₹995.85 | NSE | Moderate |
| 2017 | 21.92 | 55.48 | ₹1215.90 | NSE | Moderate |
| 2016 | 15.58 | 57.0 | ₹887.95 | NSE | Moderate |
AJANTPHARM vs Healthcare Peers — P/E Ratio Comparison
Ajanta Pharma P/E 40.43 vs Healthcare average 55.72, median 31.4 — range 2.86–916.67.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.76 | ₹30 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.41 | ₹68 | Low |
| Amwill Health Care | AMWILL | 7.26 | ₹83 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹84 | Low |
| Galaxy Medicare | GML | 7.8 | ₹27 | Low |